Skip to main content
. 2012 Oct 23;8:78. doi: 10.1186/1744-8069-8-78

Figure 2.

Figure 2

Inhibition of NK1-R in the RVM attenuates inflammatory bilateral hyperalgesia. Intra-RVM microinjection of NK1-R antagonists attenuates CFA-induced bilateral hyperalgesia. CFA (0.05 ml; 1:1 oil/saline) was injected unilaterally into the masseter muscle 24 h prior to RP67580 (A, B) and L-733,060 (C, D) microinjection into the RVM (0.5 μl). +: lowest dose vs. saline. #: middle dose vs. saline. *: highest dose vs. saline. +,#,*: p<;0.05; ++,##,**: p<;0.01; +++,###,***: p<;0.001 (ANOVA with repeated measures and Student Neuman-Keuls post-hoc test).